Home LiteratureArticle Details
PMID: 11784783 Published · ppublish English Comparative Study Journal Article

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.

Morón JA, Brockington A, Wise RA, Rocha BA, Hope BT

Abstract

Selective blockers of the norepinephrine transporter (NET) inhibit dopamine uptake in the prefrontal cortex. This suggests that dopamine in this region is normally cleared by the somewhat promiscuous NET. We have tested this hypothesis by comparing the effects of inhibitors selective for the three monoamine transporters with those of a nonspecific inhibitor, cocaine, on uptake of 3H-dopamine into synaptosomes from frontal cortex, caudate nucleus, and nucleus accumbens from wild-type, NET, and dopamine transporter (DAT) knock-out mice. Dopamine uptake was inhibited by cocaine and nisoxetine, but not by GBR12909, in frontal cortex synaptosomes from wild-type or DAT knock-out mice. At transporter-specific concentrations, nisoxetine and GBR12909 failed to block dopamine uptake into frontal cortex synaptosomes from NET knock-out mice. The efficacy of cocaine at the highest dose (1 mm) was normal in DAT knock-out mice but reduced by 70% in NET knock-out mice. Nisoxetine inhibited dopamine uptake by 20% in caudate and nucleus accumbens synaptosomes from wild-type and DAT knock-out mice but had no effect in those from NET knock-out mice. Cocaine failed to block dopamine uptake into caudate or nucleus accumbens synaptosomes from DAT knock-out mice. Cocaine and GBR12909 each inhibited dopamine uptake into caudate synaptosomes from NET knock-out mice, but cocaine effectiveness was reduced in the case of nucleus accumbens synaptosomes. Thus, whereas dopamine uptake in caudate and nucleus accumbens depends primarily on the DAT, dopamine uptake in frontal cortex depends primarily on the NET. These data underscore the fact that which transporter clears dopamine from a given region depends on both the affinities and the local densities of the transporters.

MeSH Terms
Animals Brain/metabolism Brain Chemistry Caudate Nucleus/chemistry,metabolism Cocaine/pharmacology Dopamine/metabolism,pharmacokinetics Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors/pharmacology Dose-Response Relationship, Drug Fluoxetine/analogs & derivatives,pharmacology Frontal Lobe/chemistry,metabolism Membrane Glycoproteins Membrane Transport Proteins/deficiency,genetics,metabolism Mice Mice, Knockout Nerve Tissue Proteins Norepinephrine/antagonists & inhibitors Norepinephrine Plasma Membrane Transport Proteins Nucleus Accumbens/chemistry,metabolism Piperazines/pharmacology Symporters/deficiency,genetics,metabolism Synaptosomes/chemistry,drug effects,metabolism
Chemicals
Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors Membrane Glycoproteins Membrane Transport Proteins Nerve Tissue Proteins Norepinephrine Plasma Membrane Transport Proteins Piperazines Slc6a2 protein, mouse Slc6a3 protein, mouse Symporters Fluoxetine nisoxetine vanoxerine Cocaine Dopamine Norepinephrine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Morón Jose A
Behavioral Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA.
Brockington Alicia
Wise Roy A
Rocha Beatriz A
Hope Bruce T
References (49)
49 references, click to expand
  1. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2.
    J Biol Chem. 1998 Nov 20;273(47):30915-20 PMID: 9812985
  2. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.
    J Neurochem. 1990 Sep;55(3):1067-70 PMID: 2117046
  3. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine.
    Can J Psychol. 1977 Dec;31(4):195-203 PMID: 608135
  4. Regulation of extracellular dopamine by the norepinephrine transporter.
    J Neurochem. 1998 Jul;71(1):274-80 PMID: 9648875
  5. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Eur J Pharmacol. 1977 Jan 21;41(2):133-43 PMID: 832672
  6. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5300-5 PMID: 11320258
  7. Habit-forming actions of nomifensine in nucleus accumbens.
    Psychopharmacology (Berl). 1995 Nov;122(2):194-7 PMID: 8848536
  8. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain.
    J Biol Chem. 1998 Dec 4;273(49):32776-86 PMID: 9830022
  9. Brain noradrenaline and the mechanisms of action of antidepressant drugs.
    Acta Psychiatr Scand Suppl. 2000;402:18-27 PMID: 10901155
  10. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens.
    J Neurochem. 1995 Jul;65(1):201-7 PMID: 7790861
  11. "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system.
    J Neural Transm Suppl. 1998;52:343-9 PMID: 9564637
  12. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Br J Pharmacol. 2000 Mar;129(5):1028-34 PMID: 10696105
  13. Protein kinase C activators decrease dopamine uptake into striatal synaptosomes.
    J Pharmacol Exp Ther. 1996 Jun;277(3):1527-32 PMID: 8667219
  14. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity.
    J Neurosci. 2000 Mar 1;20(5):1952-63 PMID: 10684896
  15. The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.
    J Neurosci. 1997 Sep 15;17(18):6899-907 PMID: 9278525
  16. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
    Brain Res Dev Brain Res. 2000 Feb 7;119(2):251-7 PMID: 10675775
  17. Diffusion and uptake of dopamine in rat caudate and nucleus accumbens compared using fast cyclic voltammetry.
    Brain Res. 1988 May 17;448(2):381-5 PMID: 3378163
  18. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    J Comp Neurol. 1997 Nov 17;388(2):211-27 PMID: 9368838
  19. Cellular and subcellular localization of the dopamine transporter in rat cortex.
    Adv Pharmacol. 1998;42:171-4 PMID: 9327871
  20. Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain.
    Synapse. 1996 Jul;23(3):224-31 PMID: 8807751
  21. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.
    J Biol Chem. 1994 Mar 11;269(10):7124-30 PMID: 8125921
  22. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter.
    J Comp Neurol. 2000 May 1;420(2):211-32 PMID: 10753308
  23. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
    Nature. 1996 Feb 15;379(6566):606-12 PMID: 8628395
  24. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex.
    Brain Res. 1990 Jun 18;520(1-2):303-9 PMID: 2145054
  25. Cocaine-sensitive and -insensitive dopamine uptake in prefrontal cortex, nucleus accumbens and striatum.
    Neurochem Int. 1993 Jul;23(1):61-9 PMID: 8369733
  26. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.
    Mol Pharmacol. 1998 Aug;54(2):342-52 PMID: 9687576
  27. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats.
    J Neurochem. 1994 Jul;63(1):195-200 PMID: 8207428
  28. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
    J Neurosci. 1998 Mar 15;18(6):1979-86 PMID: 9482784
  29. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?
    Psychopharmacology (Berl). 1994 Jun;115(1-2):285-8 PMID: 7862908
  30. Cloning of a serotonin transporter affected by antidepressants.
    Science. 1991 Oct 25;254(5031):579-80 PMID: 1948036
  31. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters.
    J Biol Chem. 1994 Jun 10;269(23):15985-8 PMID: 8206893
  32. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    J Pharmacol Exp Ther. 1999 May;289(2):877-85 PMID: 10215666
  33. Problems with currently available antidepressants.
    J Clin Psychiatry. 2000;61 Suppl 10:5-15 PMID: 10910012
  34. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine.
    Pharmacol Biochem Behav. 1977 Jun;6(6):615-20 PMID: 122445
  35. The dopamine transporter: immunochemical characterization and localization in brain.
    J Neurosci. 1995 Mar;15(3 Pt 1):1714-23 PMID: 7534339
  36. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates.
    Br J Pharmacol. 1973 Feb;47(2):332-8 PMID: 4722047
  37. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
    Acta Psychiatr Scand Suppl. 2000;402:12-7 PMID: 10901154
  38. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study.
    Life Sci. 1990;46(9):635-45 PMID: 2308472
  39. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine.
    Eur J Neurosci. 1997 Oct;9(10):2077-85 PMID: 9421168
  40. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors.
    Eur J Pharmacol. 1994 Oct 3;263(3):277-83 PMID: 7843265
  41. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia.
    Eur J Neurosci. 1996 Jun;8(6):1256-64 PMID: 8752596
  42. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex.
    Eur J Pharmacol. 1999 Oct 21;383(1):39-48 PMID: 10556679
  43. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram.
    J Neurochem. 1999 Sep;73(3):1051-7 PMID: 10461894
  44. Cocaine self-administration in dopamine-transporter knockout mice.
    Nat Neurosci. 1998 Jun;1(2):132-7 PMID: 10195128
  45. Dopamine transporter immunoreactivity in rat brain.
    J Comp Neurol. 1995 Aug 21;359(2):340-9 PMID: 7499533
  46. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants.
    Nat Neurosci. 2000 May;3(5):465-71 PMID: 10769386
  47. Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers.
    Neurochem Int. 1992 Mar;20 Suppl:231S-235S PMID: 1365432
  48. Genetic approaches to studying norepinephrine function: knockout of the mouse norepinephrine transporter gene.
    Biol Psychiatry. 1999 Nov 1;46(9):1124-30 PMID: 10560019
  49. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study.
    J Neurosci. 1994 Jan;14(1):442-50 PMID: 8283249
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2002-01-15
Pages
389-95
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6758674
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]